13D/13G Filings - BIOTECHNOLOGY VALUE FUND L P

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, ...14, 15, 16, 17, 18, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-01-19
5:21 pm
Purchase
2021-01-06 13G Aileron Therapeutics, Inc.
ALRN
BIOTECHNOLOGY VALUE FUND L P 13,164
6.300%
13,164increase
(New Position)
Filing
History
2021-01-14
4:48 pm
Sale
2021-01-12 13G AC Immune SA
ACIU
BIOTECHNOLOGY VALUE FUND L P 7,916,658
11.000%
-3,425,847decrease
(-30.20%)
Filing
History
2021-01-13
4:56 pm
Sale
2021-01-11 13G Cytokinetics, Incorporated
CYTK
BIOTECHNOLOGY VALUE FUND L P 2,728,035
3.900%
-4,629,984decrease
(-62.92%)
Filing
History
2021-01-12
5:10 pm
Unchanged
2021-01-08 13D PHAXIAM Therapeutics S.A.
PHXM
BIOTECHNOLOGY VALUE FUND L P 44,619
22.300%
0
(Unchanged)
Filing
History
2021-01-11
5:06 pm
Purchase
2020-12-30 13G GRITSTONE BIO INC
GRTSQ
BIOTECHNOLOGY VALUE FUND L P 2,695,418
6.500%
2,695,418increase
(New Position)
Filing
History
2020-12-30
5:27 pm
Purchase
2020-12-28 13G NOVUS THERAPEUTICS INC
NVUS
BIOTECHNOLOGY VALUE FUND L P 1,518,039
10.000%
3,520increase
(+0.23%)
Filing
History
2020-12-28
5:13 pm
Purchase
2020-12-22 13G NOVUS THERAPEUTICS INC
NVUS
BIOTECHNOLOGY VALUE FUND L P 1,514,519
9.990%
1,319,193increase
(+675.38%)
Filing
History
2020-12-21
4:37 pm
Purchase
2020-12-11 13G Lexicon Pharmaceuticals, Inc.
LXRX
BIOTECHNOLOGY VALUE FUND L P 10,963,000
7.800%
10,963,000increase
(New Position)
Filing
History
2020-12-15
5:21 pm
Unchanged
2020-12-11 13D XOMA Corporation
XOMA
BIOTECHNOLOGY VALUE FUND L P 4,182,243
37.900%
0
(Unchanged)
Filing
History
2020-12-10
5:16 pm
Sale
2020-02-04 13G Arcus Biosciences, Inc.
RCUS
BIOTECHNOLOGY VALUE FUND L P 2,752,222
4.200%
-826,801decrease
(-23.10%)
Filing
History
2020-11-20
5:23 pm
Purchase
2020-11-19 13D Olema Pharmaceuticals, Inc.
OLMA
BIOTECHNOLOGY VALUE FUND L P 6,661,503
16.600%
6,661,503increase
(New Position)
Filing
History
2020-11-16
5:29 pm
Purchase
2020-11-12 13G Cytokinetics, Incorporated
CYTK
BIOTECHNOLOGY VALUE FUND L P 7,358,019
10.400%
3,419,739increase
(+86.83%)
Filing
History
2020-11-13
5:27 pm
Sale
2020-11-11 13D FIVE PRIME THERAPEUTICS INC
FPRX
BIOTECHNOLOGY VALUE FUND L P 1,263,678
3.300%
-7,100,675decrease
(-84.89%)
Filing
History
2020-11-12
5:13 pm
Unchanged
2020-11-09 13D Infinity Pharmaceuticals, Inc.
INFIQ
BIOTECHNOLOGY VALUE FUND L P 17,426,968
27.100%
0
(Unchanged)
Filing
History
2020-11-12
5:11 pm
Purchase
2020-11-09 13G Calliditas Therapeutics AB (publ)
CALT
BIOTECHNOLOGY VALUE FUND L P 7,431,562
14.900%
2,650,000increase
(+55.42%)
Filing
History
2020-11-10
4:58 pm
Purchase
2020-11-06 13G CytomX Therapeutics, Inc.
CTMX
BIOTECHNOLOGY VALUE FUND L P 4,626,411
10.000%
1,437,463increase
(+45.08%)
Filing
History
2020-11-09
5:26 pm
Purchase
2020-10-28 13G MIRAGEN THERAPEUTICS INC
MGEN
BIOTECHNOLOGY VALUE FUND L P 7,584,219
9.990%
7,584,219increase
(New Position)
Filing
History
2020-11-03
4:39 pm
Sale
2020-10-30 13G BioLineRx Ltd.
BLRX
BIOTECHNOLOGY VALUE FUND L P 148,671
1.900%
-632,391decrease
(-80.97%)
Filing
History
2020-10-20
08:59 am
Purchase
2020-05-22 13G ContraFect Corporation
CFRX
BIOTECHNOLOGY VALUE FUND L P 36,361
9.990%
36,361increase
(New Position)
Filing
History
2020-10-13
5:18 pm
Sale
2020-10-09 13D PHAXIAM Therapeutics S.A.
PHXM
BIOTECHNOLOGY VALUE FUND L P 44,619
23.500%
-857decrease
(-1.88%)
Filing
History
Goto Prev, 0, 1, ...14, 15, 16, 17, 18, Next